Fairvalue-Calculator Fairvalue-Calculator

Ryan Specialty Holdings (RYAN) Fair Value & Analysis

Financial Services · US · Market cap $8.5B

Price$35.28
Fair Value$6.37
Upside-81.9%
Quality87/100
Evidence: Medium Range $4.77 – $7.96

Analysis

Ryan Specialty Holdings (RYAN) currently trades at $35.28, while our model-based Fair Value estimate is $6.37 — implying the stock looks roughly 81.9% overvalued today. We read business quality at 87/100 (high quality), in the Financial Services sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

About the company

Ryan Specialty Holdings, Inc. operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, rest of Europe, India, Singapore, and internationally. The company offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter or a program administrator with delegated authority from insurance carriers. It serves commercial, industrial, institutional, individual, and government sectors. The company was founded in 2010 and is headquartered in Chicago, Illinois.

Open the full interactive analysis →

Similar stocks

Fidelity National Financial, Inc (FNF) -18% Medibank Private Limited (MDBPF) -58% Beazley plc (BZLYF) +100% AXIS Capital Holdings (AXS) +68% First American Financial Corporation (FAF) +26% Enact Holdings (ACT) +41%

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.